Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2025; 15(1): 162-171


The pattern of adverse drug reactions at a National Cancer Hospital in Indonesia: Analysis of spontaneous reports from healthcare professionals

Risani Andalasia Putri, Zullies Ikawati, Fita Rahmawati, Nanang Munif Yasin, Yuri Pertamasari.




Abstract

Drug utilization is inevitably accompanied by a high potential for adverse drug reactions (ADRs), ranging from mild to life-threatening events. Studies on the pattern of ADRs reported by healthcare professionals are still limited in Indonesia. Therefore, this study aims to evaluate spontaneous ADRs reported to the monitoring unit at a national cancer hospital in Indonesia. These reactions were assessed for causality using the Naranjo Probability Scale (NPS), while severity assessment was carried out using the NCI CTCAE V.5.0 (National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0) scale. The data obtained were subjected to descriptive analysis, and a total of 553 ADRs in 280 patients reported from January 2021 to December 2022 were assessed. The results showed that the most common reactions were nausea (11.6%), vomiting (9.9%), and constipation (7.2%). In addition, morphine, docetaxel, and cisplatin were identified as the most common substances causing ADRs. Causality assessment showed that 62.4% of ADRs were “probable” and 27.8% were “definite.” Severity assessment results showed that most reactions (48.8%) were classified as grade 2 (moderate), while 29.5% were grade 1 (mild). Based on these results, the incidence of ADRs among patients was a significant concern, which required active monitoring for prompt identification and treatment.

Key words: adverse drug reactions, causality, severity, pharmacovigilance.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.